The relationship between vitamin D and PTH levels and cardiovascular risk in the elderly hypertensives

References

• Perez Lopez FR. Vitamin D and its implications for musculoskeletal health in women: an update. Maturitas 2007;58:117–37
   PubMed Web of Science ®Google Scholar
• Linnebur SA, Vondracek SF, Vande Griend JP, et al. Prevalence of vitamin D insufficiency in elderly ambulatory outpatients in Denver, Colorado. Am J Geriatr Pharmacother 2007;5:1–8
   PubMedGoogle Scholar
• Lu L, Yu Z, Pan A, et al. Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care 2009;32:1278–83
   PubMed Web of Science ®Google Scholar
• Judd SE, Nanes MS, Ziegler TR, et al. Optimal vitamin D status attenuates the age-associated increase in systolic blood pressure in white Americans: results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr 2008;87:136–41
   PubMed Web of Science ®Google Scholar
• Sheikh A, Saeed Z, Jafri SA, et al. Vitamin D levels in asymptomatic adults – a population survey in Karachi, Pakistan. PLoS One 2012;7:e33452
   PubMed Web of Science ®Google Scholar
• Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117:503–11
   PubMed Web of Science ®Google Scholar
• Li YC, Qiao G, Uskokovic M, et al. Vitamin D: a negative endocrine regulator of the renin--angiotensin system and blood pressure. J Steroid Biochem Mol Biol 2004;89–90:387–92
   PubMed Web of Science ®Google Scholar
• Vaidya A, Forman JP. Vitamin D and hypertension: current evidence and future directions. Hypertension 2010;56:774–9
   PubMed Web of Science ®Google Scholar
• Jablonski KL, Chonchol M, Pierce GL, et al. 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension 2011;57:63–9
   PubMed Web of Science ®Google Scholar
• Dong J, Wong SL, Lau CW, et al. Calcitriol protects renovascular function in hypertension by down-regulating angiotensin II type 1 receptors and reducing oxidative stress. Eur Heart J 2012;33:2980–90
   PubMed Web of Science ®Google Scholar
• Pilz S, Tomaschitz A, Ritz E, Pieber TR. Vitamin D status and arterial hypertension: a systematic review. Nat Rev Cardiol 2009;6:621–30
   PubMed Web of Science ®Google Scholar
• He JL, Scragg RK. Vitamin D, parathyroid hormone, and blood pressure in the National Health and Nutrition Examination Surveys. Am J Hypertens 2011;24:911–17
   PubMed Web of Science ®Google Scholar
• Forman JP, Giovannucci E, Holmes MD, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007;49:1063–9
   PubMed Web of Science ®Google Scholar
• Kim MK, II Kang M, Won Oh K, et al. The association of serum vitamin D level with presence of metabolic syndrome and hypertension in middle-aged Korean subjects. Clin Endocrinol (Oxf) 2010;73:330–8
   Google Scholar
• Zhao G, Ford ES, Li C, et al. Independent associations of serum concentrations of 25-hydroxyvitamin D and parathyroid hormone with blood pressure among US adults. J Hypertens 2010;28:1821–8
   PubMed Web of Science ®Google Scholar
• Forman JP, Curhan GC, Taylor EN. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension 2008;52:828–32
   PubMed Web of Science ®Google Scholar
• Jorde R, Figenschau Y, Emaus N, et al. Serum 25-hydroxyvitamin D levels are strongly related to systolic blood pressure but do not predict future hypertension. Hypertension 2010;55:792–8
   PubMed Web of Science ®Google Scholar
• Bhandari SK, Pashayan S, Liu IL, et al. 25-hydroxyvitamin D levels and hypertension rates. J Clin Hypertens (Greenwich) 2011;13:170–7
   PubMed Web of Science ®Google Scholar
• Dorjgochoo T, Ou Shu X, Xiang YB, et al. Circulating 25-hydroxyvitamin D levels in relation to blood pressure parameters and hypertension in the Shanghai Women's and Men's Health Studies. Br J Nutr 2012;108:449–58
   PubMed Web of Science ®Google Scholar
• Anderson JL, Vanwoerkom RC, Horne BD, Bair TL, May HT, Lappé DL, Muhlestein JB. Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors? Am Heart J 2011;162:331--39
   Google Scholar
• Resnick LM, Muller FB, Laragh JH. Calcium regulating hormones in essential hypertension, relation to plasma renin activity and sodium metabolism. Ann Intern Med 1986;105:649–54
   PubMed Web of Science ®Google Scholar
• Lind, L Wengle B, Wide L, Ljunghall S. Reduction of blood pressure during long-term treatment with active vitamin D (alphacalcidol) is dependent on plasma renin activity and calcium status. A double-blind, placebo-controlled study. Am J Hypertens 1989;2:20–5
   PubMed Web of Science ®Google Scholar
• Freundlich M. Suppression of renin–angiotensin gene expression in the kidney by paracalcitol. Kidney Int 2008;74:1394–402
   PubMed Web of Science ®Google Scholar
• Zittermann A. Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol 2006;92:39--48
   PubMed Web of Science ®Google Scholar
• Chan R, Chan D, Woo J, et al. Serum 25-hydroxyvitamin D and parathyroid hormone levels in relation to blood pressure in a cross-sectional study in older Chinese men. J Hum Hypertens 2012;26:20–7
   PubMed Web of Science ®Google Scholar
• Snijder MB, Lips P, Seidell JC, et al. Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women. J Intern Med 2007;261:558–65
   PubMed Web of Science ®Google Scholar
• Taylor EN, Curhan GC, Forman JP. Parathyroid hormone and the risk of incident hypertension. J Hypertens 2008;26:1390–4
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, et al.; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560–72
   Google Scholar
• D’Agostino RBS, Sullivan LM, Wilson P. Validation of the framingham Coronary heart disease prediction scares: results of a multiple ethnic groups investigation. JAMA 2001;286:180–7
   PubMed Web of Science ®Google Scholar
• Vassan RS, Larson MG, Leip EP, et al. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 2001;358:1682–6
   PubMed Web of Science ®Google Scholar
• Burgaz A, Orsini N, Larsson SC, Wolk A. Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis. J Hypertens 2011;29:636--45
   PubMed Web of Science ®Google Scholar
• Forman JP, Giovannucci E, Holmes MD. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007;49:1063–9
   PubMed Web of Science ®Google Scholar
• Judd SE, Nanes MS, Ziegler TR, et al. Optimal vitamin D status attenuates the age-associated increase in systolic blood pressure in white Americans: results from the third national health and nutrition examination survey. Am J Clin Nutr 2008;87:136--41
   PubMed Web of Science ®Google Scholar
• Skaaby T, Husemoen LL, Pisinger C, et al. Vitamin D status and changes in cardiovascular risk factors: a prospective study of a general population. Cardiology 2012;123:62–70
   PubMed Web of Science ®Google Scholar
• Caro Y, Negrón V, Palacios C. Association between vitamin D levels and blood pressure in a group of Puerto Ricans. P R Health Sci J 2012;31:123–9
   PubMed Web of Science ®Google Scholar
• Reis JP, von Mühlen D, Kritz-Silverstein D, et al. Vitamin D, parathyroid hormone levels, and the prevalence of metabolic syndrome in community-dwelling older adults. Diabetes Care 2007;30:1549–55
   PubMed Web of Science ®Google Scholar
• Margolis KL, Martin LW, Ray RM, et al; Women’s Health Initiative Investigators. A prospective study of serum 25-hydroxyvitamin D levels, blood pressure, and incident hypertension in postmenopausal women. Am J Epidemiol 2012;175:22–32
   PubMed Web of Science ®Google Scholar
• Elamin MB, Abu Elnour NO, Elamin KB, et al. Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J Clin Endocrinol Metab 2011;96:1931–42
   PubMed Web of Science ®Google Scholar
• Snijder MB, Lips P, Seidell JC, et al. Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women. J Intern Med 2007;261:558–65
   PubMed Web of Science ®Google Scholar
• Zadshir A, Tareen N, Pan D, et al. The prevalence of hypovitaminosis D among US adults: data from the NHANES III. Ethn Dis 2005;15:97–101
   PubMedGoogle Scholar
• Gonzalez-Clemente JM, Martinez-Osaba MJ, Minarro A, et al. Hypovitaminosis D: its high prevalence in elderly outpatients in Barcelona. Associated factors. Med Clin (Barc) 1999;113:641–5
   PubMed Web of Science ®Google Scholar
• Aguado P, Garces MV, Gonzalez Casaus ML, et al. High prevalence of vitamin D deficiency in postmenopausal women at a rheumatology office in Madrid. Evaluation of two vitamin D prescription regimens. Med Clin (Barc) 2000;114:326–30
   PubMed Web of Science ®Google Scholar
• Anderson JL, May HT, Horne BD, et al; Intermountain Heart Collaborative (IHC) Study Group. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 2010;106:963–8
   PubMed Web of Science ®Google Scholar
• Lee JH, O'Keefe JH, Bell D, et al. Vitamin D deficiency an important, common, and easily treatable cardiovascular risk factor? J Am Coll Cardiol 2008;52:1949–56
   PubMed Web of Science ®Google Scholar
• Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266–81
   PubMed Web of Science ®Google Scholar
• Anderson JL, Vanwoerkom RC, Horne BD, et al. Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors? Am Heart J 2011;162:331–9
   PubMed Web of Science ®Google Scholar
• Pilz S, Tomaschitz A, März W, et al. Vitamin D, cardiovascular disease and mortality. Clin Endocrinol (Oxf) 2011;75:575–84
   PubMed Web of Science ®Google Scholar
• Hulter HN, Melby JC, Peterson JC, Cooke CR. Chronic continuous PTH infusion results in hypertension in normal subjects. J Clin Hypertens 1986;2:360–70
   PubMedGoogle Scholar
• Rostland SG, Drueke TB. Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int 1999;56:383–92
   PubMed Web of Science ®Google Scholar
• Andersson P, Rydberg E, Willenheimer R. Primary hyperparathyroidism and heart disease – a review. Eur Heart J 2004;25:1776–87
   PubMed Web of Science ®Google Scholar
• Kamycheva E, Sundsfjord J, Jorde R. Serum parathyroid hormone levels predict coronary heart disease: the Tromso Study. Eur J Cardiovasc Prevent Rehabil 2004;11:69–74
   PubMed Web of Science ®Google Scholar
• Bollerslev J, Rosen T, Mollerup CL, et al; SIPH Study Group. Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism. J Clin Endocrinol Metab 2009;94:2255–61
   PubMed Web of Science ®Google Scholar